Erfan Aref‐Eshghi

3.1k citations
48 papers · 1.3k indexed · h-index 21
Topics
Epigenetics and DNA Methylation (13 papers)Osteoarthritis Treatment and Mechanisms (11 papers)Genomics and Rare Diseases (10 papers)

In The Last Decade

Erfan Aref‐Eshghi

47 papers receiving 1.3k citations

Peers

Erfan Aref‐Eshghi
Comparison fields: 5 of 107
  • Molecular Biology 772
  • Genetics 397
  • Cancer Research 299
  • Rheumatology 287
  • Surgery 123
Replace Sung Won Lee with:
Sung Won Lee South Korea
Koon Soon Kim South Korea
Momoko Horikoshi Japan
Aleksandra Stanković Serbia
Minoru Okubo Japan
Nihan Kavaslar Canada
Brian L. Dake United States
Hilma Hólm Iceland
Laurent F. Thomas Norway
Barbara Ostanek Slovenia
Erfan Aref‐Eshghi relative to Sung Won Lee South Korea Sung Won Lee's profile →
Citations per field
00.5×7.6×
Sung Won Lee · 1×
Citations per year

Countries citing papers authored by Erfan Aref‐Eshghi

Since Specialization
Citations

This map shows the geographic impact of Erfan Aref‐Eshghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erfan Aref‐Eshghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erfan Aref‐Eshghi more than expected).

Fields of papers citing papers by Erfan Aref‐Eshghi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erfan Aref‐Eshghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erfan Aref‐Eshghi. The network helps show where Erfan Aref‐Eshghi may publish in the future.

Co-authorship network of co-authors of Erfan Aref‐Eshghi

This figure shows the co-authorship network connecting the top 25 collaborators of Erfan Aref‐Eshghi. A scholar is included among the top collaborators of Erfan Aref‐Eshghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erfan Aref‐Eshghi. Erfan Aref‐Eshghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 6
4 4
5 21
6 19
7 90
8 34
9 35
10 26
11 15
12 94
13 2
14 14
15 1
16 45
17 28
18 36
19 93
20 17

About Erfan Aref‐Eshghi

Erfan Aref‐Eshghi is a scholar working on Cancer Research, Rheumatology and Genetics, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (13 papers), Osteoarthritis Treatment and Mechanisms (11 papers) and Genomics and Rare Diseases (10 papers). The work is most often cited by research in Cancer Research (299 citations), Rheumatology (287 citations) and Genetics (397 citations). Erfan Aref‐Eshghi has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Bekim Sadiković, David I. Rodenhiser, Hanxin Lin, Peter Ainsworth, Glynn Martin, Andrew Furey, Guangju Zhai, Proton Rahman, Patricia E. Harper and Laila C. Schenkel. Their work appears in journals such as PLoS ONE, Diabetes and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026